恆發光學(01134.HK)成立項目團隊以開發新業務
格隆匯3月28日丨恆發光學(01134.HK)發佈公告,自2019年年底以來,集團一直在探索新商機,致力為股東帶來更高回報,其中之一為山茶油和護膚品行業。2019年底,集團的全資子公司秦湘油茶科技香港有限公司同意出任總部位於湖南省懷化市的懷化秦湘油業有限公司的銷售代理,以在中國銷售懷化秦湘所生產的山茶油和護膚品。然而,由於中國爆發2019冠狀病毒病,新業務延後開展。隨着最近2019冠狀病毒病在中國逐漸被遏制,集團恢復與懷化秦湘關於合作模式的討論,截至該公佈之日,集團已成立一支項目團隊以開發新業務。
公告表示,集團大部分眼鏡產品銷往歐洲市場,監於2019冠狀病毒病疫情對全球經濟(特別是歐洲)帶來的不確定性,集團相信,開展新業務將會為集團實現主營業務及收入來源多元化帶來新的良機,並可減輕由於向歐洲客户的銷售減少(如有此情況)而導致集團收入的任何潛在減少的影響。因此,董事會相信發展新業務將對集團的財務表現有利並符合公司及股東的整體利益。儘管本集團有意發展新業務,但集團在眼鏡產品製造和銷售方面的現有主營業務將繼續是集團的核心業務。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.